Review Article
Effect of Ulinastatin in the Treatment of Postperative Cognitive Dysfunction: Review of Current Literature
Table 2
Secondary outcomes reported by included studies.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Note: U: ulinastatin group; C: control group; preoperative; at the end of operation; three hours after operation; six hours after operation; one day after operation; two days after operation; three days after operation; from preoperation in group U and group C (statistically significant); from group C (statistically significant). Ge et al., 2015 (1): high-dose ulinastatin (16000 U/kg); Ge et al., 2015 (2): low-dose ulinastatin (8000 U/kg). |